| Project | Total Investment | Production Scale (Thousand) | Sales Revenue | ROI | Input-Output Ratio | Dynamic Payback |
| Doxazosin Mesylate New APIs and Formulations Production Line | 60,000 | 130,000 | 104,000 | 59.55% | 1:2.97 | 2.83 |
| Propiverine Hydrochloride New APIs and Formulations Production Line | 40,000 | 100,000 | 200,000 | 116.50% | 1:1.67 | 2.08 |
| Paracetamol and Pseudoephedrine Tablets (Kangmei Lee Type) to Expand Production Scale | 40,000 | 100,000 | 110,000 | 37.43% | 1:7.33 | 4.17 |
| New Formulations of Clarithromycin Tablet Production Line | 30,000 | 20,000 | 120,000 | 27.50% | 1:8 | 2.5 |